Abbott earns FDA approval for new dual-energy ablation catheter

Abbott (NYSE: ABT) earned FDA approval for its new dual-energy catheter, TactiFlex Duo sensor-enabled ablation catheter. […] Abbott (NYSE: ABT) earned FDA approval for its new dual-energy catheter, TactiFlex Duo sensor-enabled ablation catheter. The catheter combines pulsed-field ablation (PFA) and radiofrequency (FR) energy to treat patients with difficult atrial fibrillation cases. Abbot says the combination of both technologies allows physicians greater flexibility in a single procedure, 'helping them tailor treatment to each patient's anatomy and clinical needs while minimizing impact on surrounding healthy tissue.' Read full article: https://www.massdevice.com/abbott-earns-fda-approval-for-new-dual-energy-ablation-catheter/